Unusual 11 Mid-Day Movers 06/25: (JAX) (ALSK) (BIOL) Higher; (VTUS) (GEOY) (MNTA) Lower
Tweet Send to a Friend
Ventrus Biosciences, Inc. (Nasdaq: VTUS) 59.3% LOWER; today reported that its Phase 3, randomized, double-blind, placebo-controlled clinical trial of iferanserin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
